Completed PHASE3 INTERVENTIONAL 2-arm NCT05000658

Efficacy of Soluble Dexamethasone in Refractory Sciatica (Dexhia)

Efficacy of Soluble Dexamethasone by Echo-guided Infiltration Through the Sacrococcygeal Hiatus in Refractory Sciatica: a Prospective Randomised Double-blind Study Versus Placebo

Sponsor: Nantes University Hospital

Conditions Sciatica

Interventions Dexamethasone phosphate

Updated 5 times since 2021 Last updated: Jan 31, 2024 Started: Dec 16, 2021 Primary completion: Mar 15, 2023 Completion: Mar 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Sciatica and is currently completed. Nantes University Hospital leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2024 — Jul 2024 [monthly]

Completed PHASE3

Status: Recruiting → Completed
May 2022 — Mar 2024 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Sep 2021 — May 2022 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nantes University Hospital

Data source: Nantes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nantes, France